Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic brinzolamide versus Azopt in open-angle glaucoma and ocular hypertension
2011-003692-12Phase 3Completed
- Sponsor
- AZAD Pharma AG
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of brinzolamide in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by AZAD Pharma AG. Primary endpoint: Primary efficacy endpoint. Started Jan 2012; status: completed.
02
Drugs
brinzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2011-003692-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003692-12.